Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
The Battery ShowThe Battery Show
Not Confirmed
Not Confirmed
06-09 October, 2025
Not Confirmed
Not Confirmed
07-09 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
The Battery ShowThe Battery Show
Industry Trade Show
Not Confirmed
06-09 October, 2025
Industry Trade Show
Not Confirmed
07-09 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-bridge-the-gap-between-chemistry-and-performance-to-deliver-precise-optimized-micronization-for-complex-apis
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
02 Oct 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/vanda-and-fda-make-nice-agreeing-squash-several-disputes-following-appeals-court-win
25 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-the-publication-in-plos-one-of-an-article-titled-melatonin-agonist-tasimelteon-hetlioz-improves-sleep-in-patients-with-primary-insomnia-a-multicenter-randomized-double-blind-placebo-controll-302567056.html
28 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-september-2025-investor-conferences-302541540.html
28 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-fda-granted-orphan-drug-designation-for-vgt-1849b-a-novel-and-selective-candidate-for-the-treatment-of-polycythemia-vera-302540649.html
21 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/vanda-seeks-fda-commissioner-review-of-outgoing-cder-directors-decision-to-uphold-approval-of-two-generic-versions-of-hetlioz-302536237.html
18 Aug 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/vanda-scores-landmark-win-over-fda-years-long-dispute-over-hetlioz-jet-lag-disorder-bid
ABOUT THIS PAGE